DaVita Inc
DVA121.370USD
+1.880+1.57%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
8.61BMarket Cap
11.16P/E TTM
More Details of DaVita Inc Company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
DaVita Inc Info
Ticker SymbolDVA
Company nameDaVita Inc
IPO dateOct 31, 1995
CEOMr. Javier J. Rodriguez
Number of employees76000
Security typeOrdinary Share
Fiscal year-endOct 31
Address2000 16th St
CityDENVER
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code80202-5117
Phone13105362668
Websitehttps://www.davita.com/
Ticker SymbolDVA
IPO dateOct 31, 1995
CEOMr. Javier J. Rodriguez
Company Executives of DaVita Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-0.62%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+1.58%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.28K
-14.14%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.98K
+3.03%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
13.44K
+3.15%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
13.08K
-36.44%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.23K
+6.03%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-0.62%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+1.58%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.28K
-14.14%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
1.66B
49.11%
Patient service - Commercial
1.04B
30.72%
Patient service - Other government
308.04M
9.11%
Patient service - Medicaid and Managed Medicaid
217.70M
6.44%
Other - Medicare and Medicare Advantage
140.15M
4.15%
Other
15.79M
0.47%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
1.66B
49.11%
Patient service - Commercial
1.04B
30.72%
Patient service - Other government
308.04M
9.11%
Patient service - Medicaid and Managed Medicaid
217.70M
6.44%
Other - Medicare and Medicare Advantage
140.15M
4.15%
Other
15.79M
0.47%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
Other
39.97%
Shareholders
Shareholders
Proportion
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
5.96%
BlackRock Institutional Trust Company, N.A.
3.39%
Weschler (R Ted)
3.09%
State Street Investment Management (US)
2.60%
Other
39.97%
Shareholder Types
Shareholders
Proportion
Holding Company
44.99%
Investment Advisor
25.66%
Investment Advisor/Hedge Fund
14.46%
Hedge Fund
5.46%
Individual Investor
5.06%
Research Firm
2.42%
Pension Fund
2.16%
Bank and Trust
0.87%
Sovereign Wealth Fund
0.35%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1270
35.96M
50.94%
-3.88M
2025Q2
1278
73.92M
100.87%
-6.43M
2025Q1
1300
76.19M
99.78%
-5.46M
2024Q4
1260
79.70M
99.28%
-3.76M
2024Q3
1214
80.97M
98.10%
-3.96M
2024Q2
1180
82.28M
96.62%
-4.32M
2024Q1
1166
84.15M
95.98%
-4.07M
2023Q4
1163
84.91M
95.56%
-3.04M
2023Q3
1159
85.40M
93.52%
-3.20M
2023Q2
1164
84.27M
92.30%
-4.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Berkshire Hathaway Inc.
32.16M
44.98%
-1.64M
-4.84%
Jul 31, 2025
The Vanguard Group, Inc.
4.73M
6.61%
-306.08K
-6.08%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.64M
3.69%
-276.40K
-9.48%
Jun 30, 2025
Weschler (R Ted)
2.18M
3.05%
--
--
Aug 06, 2024
State Street Investment Management (US)
2.09M
2.93%
-103.39K
-4.71%
Jun 30, 2025
Invesco Capital Management LLC
1.34M
1.88%
+33.33K
+2.55%
Jun 30, 2025
Gates Capital Management, Inc.
1.10M
1.54%
+376.77K
+52.17%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
997.53K
1.4%
+120.21K
+13.70%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.11M
1.55%
-76.77K
-6.47%
Jun 30, 2025
LSV Asset Management
940.73K
1.32%
-21.60K
-2.24%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Strategas Global Policy Opportunities ETF
1.99%
SPDR S&P Health Care Services ETF
1.91%
Aztlan Global Stock Selection DM SMID ETF
1.84%
Invesco S&P 500 Equal Weight Health Care ETF
1.65%
Global X US Cash Flow Kings 100 ETF
1.52%
Pacer US Cash Cows Growth ETF
1.1%
LeaderShares AlphaFactor US Core ETF
1%
Global X Aging Population ETF
0.81%
iShares U.S. Healthcare Providers ETF
0.78%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.75%
View more
Strategas Global Policy Opportunities ETF
Proportion1.99%
SPDR S&P Health Care Services ETF
Proportion1.91%
Aztlan Global Stock Selection DM SMID ETF
Proportion1.84%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.65%
Global X US Cash Flow Kings 100 ETF
Proportion1.52%
Pacer US Cash Cows Growth ETF
Proportion1.1%
LeaderShares AlphaFactor US Core ETF
Proportion1%
Global X Aging Population ETF
Proportion0.81%
iShares U.S. Healthcare Providers ETF
Proportion0.78%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proportion0.75%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of DaVita Inc?
The top five shareholders of DaVita Inc are:
Berkshire Hathaway Inc. holds 32.16M shares, accounting for 44.98% of the total shares.
The Vanguard Group, Inc. holds 4.73M shares, accounting for 6.61% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.64M shares, accounting for 3.69% of the total shares.
Weschler (R Ted) holds 2.18M shares, accounting for 3.05% of the total shares.
State Street Investment Management (US) holds 2.09M shares, accounting for 2.93% of the total shares.
Berkshire Hathaway Inc. holds 32.16M shares, accounting for 44.98% of the total shares.
The Vanguard Group, Inc. holds 4.73M shares, accounting for 6.61% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.64M shares, accounting for 3.69% of the total shares.
Weschler (R Ted) holds 2.18M shares, accounting for 3.05% of the total shares.
State Street Investment Management (US) holds 2.09M shares, accounting for 2.93% of the total shares.
What are the top three shareholder types of DaVita Inc?
The top three shareholder types of DaVita Inc are:
Berkshire Hathaway Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Berkshire Hathaway Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of DaVita Inc (DVA)?
As of 2025Q3, 1270 institutions hold shares of DaVita Inc, with a combined market value of approximately 35.96M, accounting for 50.94% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -49.93%.
What is the biggest source of revenue for DaVita Inc?
In FY2025Q2, the Patient service - Medicare and Medicare Advantage business generated the highest revenue for DaVita Inc, amounting to 1.66B and accounting for 49.11% of total revenue.
